Chief Financial Officer · Altimmune, Inc. (ALT)

Richard Eisenstadt

A named executive officer of Altimmune in every fiscal year CompBrief holds from FY2021 to FY2022. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$619,694

Salary $426,635Stock awards $0

FY2021: $1,715,450

4th of 4 named executive officers at Altimmune by FY2022 total.

4 named officers on file for Altimmune, FY2022

Richard Eisenstadt’s pay file — $29

  • 2 fiscal years of pay, line by line
  • ALT’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Altimmune’s whole pay program stands against its peers

  • Altimmune’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ALT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed August 16, 2023 (DEF 14A).

Free

Get Richard Eisenstadt’s full pay file as a PDF — free

More than this page: up to 10 years of Richard’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Richard Eisenstadt compensation by year

Altimmune Summary Compensation Table · all 2 fiscal years held
In US dollars, as Altimmune reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022
Salary$0$426,635
Bonus$0$0
Stock awards$458,000$0
Option awards$1,137,450$0
Non-equity incentive$120,000$170,000
Pension and deferred compensation$0$0
All other$0$23,059
Total$1,715,450$619,694

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Altimmune, Inc. DEF 14A filed August 16, 2023, accession 0001558370-23-015034, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Altimmune, Inc. filed document, accession 0001558370-23-015034. Every figure is read from that document and cited to the page and table it appears in. Filed August 16, 2023.

$1.7M
$620K
FY21
FY22
SalaryNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
RSU37,500$616,875—
Option112,500—$9.16

Per the Outstanding Equity Awards at Fiscal Year-End table in Altimmune, Inc.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.

Altimmune’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Vipin GargChief Executive Officer$2,880,424
M. Scott HarrisChief Medical Officer$1,449,618
M. Scot RobertsChief Scientific Officer$1,405,833
Richard Eisenstadt · this pageChief Financial Officer$619,694

The full Altimmune compensation record

free company brief

This page is one person within Altimmune's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Altimmune's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Richard Eisenstadt's compensation dossier · One-time report. No refunds.